These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26591062)

  • 1. [PRODUCTION AND CHARACTERIZATION OF THE PANEL OF MONOCLONAL ANTIBODIES AGAINST HUMAN ENDOGLIN].
    Smirnov IV; Gryazeva IV; Samoilovich MP; Terekhina LA; Pinevich AA; Krylova AA; Krutetskaia IY; Nikolsky NN; Klimovich VB
    Tsitologiia; 2015; 57(7):499-508. PubMed ID: 26591062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours.
    Fonsatti E; Nicolay HJ; Altomonte M; Covre A; Maio M
    Cardiovasc Res; 2010 Apr; 86(1):12-9. PubMed ID: 19812043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments.
    Pichuantes S; Vera S; Bourdeau A; Pece N; Kumar S; Wayner EA; Letarte M
    Tissue Antigens; 1997 Sep; 50(3):265-76. PubMed ID: 9331949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of a high-affinity nanobody against human endoglin.
    Ahmadvand D; Rasaee MJ; Rahbarizadeh F; Mohammadi M
    Hybridoma (Larchmt); 2008 Oct; 27(5):353-60. PubMed ID: 18847348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-beta in suppression of growth of human endothelial cells.
    She X; Matsuno F; Harada N; Tsai H; Seon BK
    Int J Cancer; 2004 Jan; 108(2):251-7. PubMed ID: 14639611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endoglin (CD105)--a target for visualization and anti-angiogenic therapy for malignant tumors].
    Smirnov IV; Gryazeva IV; Samoilovich MP; Klimovich VB
    Vopr Onkol; 2015; 61(6):898-907. PubMed ID: 26995976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells.
    St-Jacques S; Cymerman U; Pece N; Letarte M
    Endocrinology; 1994 Jun; 134(6):2645-57. PubMed ID: 8194490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bispecific single-chain diabody-immunoliposomes targeting endoglin (CD105) and fibroblast activation protein (FAP) simultaneously.
    Rabenhold M; Steiniger F; Fahr A; Kontermann RE; Rüger R
    J Control Release; 2015 Mar; 201():56-67. PubMed ID: 25617725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective anti-angiogenic therapy of established tumors in mice by naked anti-human endoglin (CD105) antibody: differences in growth rate and therapeutic response between tumors growing at different sites.
    Tsujie M; Uneda S; Tsai H; Seon BK
    Int J Oncol; 2006 Nov; 29(5):1087-94. PubMed ID: 17016638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies.
    Matsuno F; Haruta Y; Kondo M; Tsai H; Barcos M; Seon BK
    Clin Cancer Res; 1999 Feb; 5(2):371-82. PubMed ID: 10037187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin.
    Takahashi N; Kawanishi-Tabata R; Haba A; Tabata M; Haruta Y; Tsai H; Seon BK
    Clin Cancer Res; 2001 Mar; 7(3):524-32. PubMed ID: 11297243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105).
    Toi H; Tsujie M; Haruta Y; Fujita K; Duzen J; Seon BK
    Int J Cancer; 2015 Jan; 136(2):452-61. PubMed ID: 24866768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy.
    Nassiri F; Cusimano MD; Scheithauer BW; Rotondo F; Fazio A; Yousef GM; Syro LV; Kovacs K; Lloyd RV
    Anticancer Res; 2011 Jun; 31(6):2283-90. PubMed ID: 21737653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy.
    Burrows FJ; Derbyshire EJ; Tazzari PL; Amlot P; Gazdar AF; King SW; Letarte M; Vitetta ES; Thorpe PE
    Clin Cancer Res; 1995 Dec; 1(12):1623-34. PubMed ID: 9815965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker.
    Pizarro CB; Oliveira MC; Pereira-Lima JF; Leães CG; Kramer CK; Schuch T; Barbosa-Coutinho LM; Ferreira NP
    Neuropathology; 2009 Feb; 29(1):40-4. PubMed ID: 18673444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble MMP-14 produced by bone marrow-derived stromal cells sheds epithelial endoglin modulating the migratory properties of human breast cancer cells.
    Tobar N; Avalos MC; Méndez N; Smith PC; Bernabeu C; Quintanilla M; Martínez J
    Carcinogenesis; 2014 Aug; 35(8):1770-9. PubMed ID: 24618373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of mesenchymal stem cells with magnetic nanosorbents carrying CD105 and CD73 antibodies in flow-through and batch systems.
    Odabaş S; Sayar F; Güven G; Yanikkaya-Demirel G; Pişkin E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):74-80. PubMed ID: 18078794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of anti-DC-SIGN monoclonal antibodies capable of blocking HIV-1 gp120 binding and reactive on formalin-fixed tissue.
    Canard B; Vachon H; Fontaine T; Pin JJ; Paul S; Genin C; Mueller CG
    Immunol Lett; 2011 Mar; 135(1-2):165-72. PubMed ID: 21078343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.